Cargando…
Current Trends in Neoantigen-Based Cancer Vaccines
Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens, these vaccines can be in various forms such as m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056833/ https://www.ncbi.nlm.nih.gov/pubmed/36986491 http://dx.doi.org/10.3390/ph16030392 |
_version_ | 1785016219785494528 |
---|---|
author | Ho, Szu-Ying Chang, Che-Mai Liao, Hsin-Ni Chou, Wan-Hsuan Guo, Chin-Lin Yen, Yun Nakamura, Yusuke Chang, Wei-Chiao |
author_facet | Ho, Szu-Ying Chang, Che-Mai Liao, Hsin-Ni Chou, Wan-Hsuan Guo, Chin-Lin Yen, Yun Nakamura, Yusuke Chang, Wei-Chiao |
author_sort | Ho, Szu-Ying |
collection | PubMed |
description | Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens, these vaccines can be in various forms such as messenger (m)RNA and synthetic peptides to activate cytotoxic T cells and act with or without dendritic cells. Growing evidence suggests that neoantigen-based cancer vaccines possess a very promising future, yet the processes of immune recognition and activation to relay identification of a neoantigen through the histocompatibility complex (MHC) and T-cell receptor (TCR) remain unclear. Here, we describe features of neoantigens and the biological process of validating neoantigens, along with a discussion of recent progress in the scientific development and clinical applications of neoantigen-based cancer vaccines. |
format | Online Article Text |
id | pubmed-10056833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100568332023-03-30 Current Trends in Neoantigen-Based Cancer Vaccines Ho, Szu-Ying Chang, Che-Mai Liao, Hsin-Ni Chou, Wan-Hsuan Guo, Chin-Lin Yen, Yun Nakamura, Yusuke Chang, Wei-Chiao Pharmaceuticals (Basel) Review Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens, these vaccines can be in various forms such as messenger (m)RNA and synthetic peptides to activate cytotoxic T cells and act with or without dendritic cells. Growing evidence suggests that neoantigen-based cancer vaccines possess a very promising future, yet the processes of immune recognition and activation to relay identification of a neoantigen through the histocompatibility complex (MHC) and T-cell receptor (TCR) remain unclear. Here, we describe features of neoantigens and the biological process of validating neoantigens, along with a discussion of recent progress in the scientific development and clinical applications of neoantigen-based cancer vaccines. MDPI 2023-03-05 /pmc/articles/PMC10056833/ /pubmed/36986491 http://dx.doi.org/10.3390/ph16030392 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ho, Szu-Ying Chang, Che-Mai Liao, Hsin-Ni Chou, Wan-Hsuan Guo, Chin-Lin Yen, Yun Nakamura, Yusuke Chang, Wei-Chiao Current Trends in Neoantigen-Based Cancer Vaccines |
title | Current Trends in Neoantigen-Based Cancer Vaccines |
title_full | Current Trends in Neoantigen-Based Cancer Vaccines |
title_fullStr | Current Trends in Neoantigen-Based Cancer Vaccines |
title_full_unstemmed | Current Trends in Neoantigen-Based Cancer Vaccines |
title_short | Current Trends in Neoantigen-Based Cancer Vaccines |
title_sort | current trends in neoantigen-based cancer vaccines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056833/ https://www.ncbi.nlm.nih.gov/pubmed/36986491 http://dx.doi.org/10.3390/ph16030392 |
work_keys_str_mv | AT hoszuying currenttrendsinneoantigenbasedcancervaccines AT changchemai currenttrendsinneoantigenbasedcancervaccines AT liaohsinni currenttrendsinneoantigenbasedcancervaccines AT chouwanhsuan currenttrendsinneoantigenbasedcancervaccines AT guochinlin currenttrendsinneoantigenbasedcancervaccines AT yenyun currenttrendsinneoantigenbasedcancervaccines AT nakamurayusuke currenttrendsinneoantigenbasedcancervaccines AT changweichiao currenttrendsinneoantigenbasedcancervaccines |